BVT 3498
Alternative Names: AMG 331Latest Information Update: 09 Sep 2005
At a glance
- Originator Biovitrum
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action 11-beta-hydroxysteroid dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 08 Sep 2005 Discontinued - Phase-II for Type-2 diabetes mellitus in Finland (unspecified route)
- 08 Sep 2005 Discontinued - Phase-II for Type-2 diabetes mellitus in Sweden (unspecified route)
- 24 Aug 2005 This compound is still in active development - (BIO-2005)